Challenges in Pre-Analytical Error Detection: Impact of Hemolysis and Potential Solutions

Werfen hosted an industry workshop at the ADLM 2024 Annual Meeting with an Expert Panel, focused on the challenges in pre-analytical error detection, including hemolysis, its prevalence and impact on clinical outcomes,  current strategies, and a new technology to detect hemolysis to mitigate risk at the point of care.

Challenges in Pre-Analytical Error Detection: Impact of Hemolysis and Potential Solutions

Featured Speakers

Alan Wu, PhD

Co-Core Lab Director, Zuckerberg San Francisco General Hospital, San Francisco, CA
Professor Laboratory Medicine, Chief, Clinical Pharmacogenomics Laboratory, University of California, San Francisco, CA

Christopher Farnsworth, PhD

Associate Professor, Department of Pathology and Immunology
Medical Director of Clinical Chemistry Point of Care Testing, Washington University School of Medicine, St. Louis, MO